PLRX - Equipment makers on watch as Citi unveils positive catalyst watch; Invitae upgraded on Softbank investment and more in today's analyst action

Citi expects makers of healthcare equipment to recover as vaccinations drive down COVID-19 infections and procedures return. Surging Invitae after Softbank-backed investment gets another boost as Oppenheimer upgrades the stock. Equipment makers to benefit from recovery trade Citi analysts are weighing in on the impact of the expected increase in procedures on healthcare equipment makers, as the vaccinations blunt the pandemic effect.Predicting orthopedic stocks to first benefit from the so-called ‘recovery-trade’ followed by general surgery and structural heart procedures, the firm opens positive catalyst watch on Zimmer Biomet Holdings (ZBH), Stryker Corporation (SYK), Medtronic, and Boston Scientific (BSX).Stryker Corp was also included as a buy in Bank of America’s highest conviction picks list for Q2. Invitae upgraded on Softbank investment Invitae (NVTA) has added ~10.3% in the pre-market following the news reports of a Softbank-led investment of more than $1B.The financing is expected to broaden the genetic test maker’s platform, and it is

For further details see:

Equipment makers on watch as Citi unveils positive catalyst watch; Invitae upgraded on Softbank investment and more in today’s analyst action